Skip to main content
Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
4.850
-0.500 (-9.35%)
May 14, 2025, 10:34 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022
Period Ending
 Dec '23 Dec '22
Artificial Intelligence-driven DNA Biomarker Testing Technology
17.07K
Log In
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth
1696.32%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022
Period Ending
 Dec '23 Dec '22
United States
17.07K
Log In
United States Growth
1696.32%
Log In